David S. Reasner

1.1k total citations
41 papers, 729 citations indexed

About

David S. Reasner is a scholar working on Gastroenterology, Surgery and Pharmacology. According to data from OpenAlex, David S. Reasner has authored 41 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Gastroenterology, 13 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in David S. Reasner's work include Gastrointestinal motility and disorders (15 papers), Gastroesophageal reflux and treatments (9 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). David S. Reasner is often cited by papers focused on Gastrointestinal motility and disorders (15 papers), Gastroesophageal reflux and treatments (9 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). David S. Reasner collaborates with scholars based in United States, Australia and Singapore. David S. Reasner's co-authors include Thomas E. Rollins, Rachael L. DiSantostefano, George Bensch, Sandra M. Gawchik, Harold S. Nelson, Paul Rubin, Warren Pleskow, Michael Noonan, Robert E. Johnston and Jennifer Hanlon and has published in prestigious journals such as Blood, Gastroenterology and Pain.

In The Last Decade

David S. Reasner

41 papers receiving 698 citations

Peers

Countries citing papers authored by David S. Reasner

Since Specialization

Citations

This map shows the geographic impact of David S. Reasner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Reasner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Reasner more than expected).

Fields of papers citing papers by David S. Reasner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Reasner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Reasner. The network helps show where David S. Reasner may publish in the future.

Co-authorship network of co-authors of David S. Reasner

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Reasner. A scholar is included among the top collaborators of David S. Reasner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Reasner. David S. Reasner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: A Good Practices Report of an ISPOR Task Force 2023 ·Value in Health ·Paul O’Donohoe, David S. Reasner, (unknown), Bill Byrom, Sonya Eremenco, Alexandra I. Barsdorf, (unknown), Stephen Joel Coons	10
2	Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically 2022 ·Therapeutic Innovation & Regulatory Science ·Sarah Gordon, (unknown), (unknown), Alexandra I. Barsdorf, J. A. Cohen, Mabel Crescioni, (unknown), (unknown), (unknown), David S. Reasner, Susan Vallow, (unknown), Sonya Eremenco	9
3	Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings 2022 ·Journal of Patient-Reported Outcomes ·Stacie Hudgens, Louise Newton, Sonya Eremenco, Mabel Crescioni, Tara Symonds, (unknown), David S. Reasner, Bill Byrom, Paul O’Donohoe, Susan Vallow	5
4	Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: qualitative interview findings 2022 ·Journal of Patient-Reported Outcomes ·Louise Newton, (unknown), Sonya Eremenco, Stacie Hudgens, Mabel Crescioni, Tara Symonds, David S. Reasner, Bill Byrom, Paul O’Donohoe, Susan Vallow	4
5	IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial 2020 ·Gastroenterology ·Michael F. Vaezi, Ronnie Fass, Nimish Vakil, David S. Reasner, Robert S. Mittleman, Michael Hall, James Shao, Yan Chen, (unknown), (unknown), Mark G. Currie	29
6	Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms–Constipation Using Phase IIb Clinical Trial Data 2020 ·Value in Health ·Cheryl D. Coon, Jennifer Hanlon, (unknown), J. Jason Lundy, Robyn T. Carson, David S. Reasner	9
7	Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF) 2020 ·American Heart Journal ·James E. Udelson, Gregory D. Lewis, Sanjiv J. Shah, Michael R. Zile, Margaret M. Redfield, John C. Burnett, Robert S. Mittleman, Albert T. Profy, Jelena Seferović, David S. Reasner, Marvin A. Konstam	11
8	Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions 2018 ·Journal of Gastroenterology and Hepatology ·Yunsheng Yang, (unknown), Jing‐Yuan Fang, Xiaozhong Guo, Ning Dai, Xizhong Shen, Youlin Yang, Jing Sun, Bal Raj Bhandari, David S. Reasner, (unknown), Mark G. Currie, Jeffrey M. Johnston, Peter YF. Zeng, (unknown), (unknown), Sam Lim	39
9	PRS87 - COMPARABILITY OF A PROVISIONED DEVICE VERSUS BRING YOUR OWN DEVICE FOR COMPLETION OF PATIENT-REPORTED OUTCOME (PRO) MEASURES BY PARTICIPANTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): QUALITATIVE INTERVIEW FINDINGS 2018 ·Value in Health ·Louise Newton, (unknown), Sonya Eremenco, Stacie Hudgens, Mabel Crescioni, (unknown), David S. Reasner, Bill Byrom, Paul O’Donohoe, S. Vallow	1
10	PGI46 - PSYCHOMETRIC EVALUATION OF THE DIARY FOR IRRITABLE BOWEL SYNDROME SYMPTOMS-CONSTIPATION (DIBSS-C) 2018 ·Value in Health ·Sheri Fehnel, (unknown), (unknown), Robyn T. Carson, David S. Reasner, Jennifer Hanlon, Sonya Eremenco, (unknown)	1
11	Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD) 2017 ·The American Journal of Gastroenterology ·Fiona Taylor, (unknown), Robyn T. Carson, Sonya Eremenco, Catherine Foley, Brian E. Lacy, Henry P. Parkman, David S. Reasner, Alan L. Shields, Jan Tack, Nicholas J. Talley	20
12	Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial 2017 ·The American Journal of Gastroenterology ·Philip Schoenfeld, Brian E. Lacy, William D. Chey, Anthony Lembo, Caroline B. Kurtz, David S. Reasner, Wieslaw Bochenek, (unknown), Mark G. Currie, Susan M. Fox, Rick E. Blakesley, (unknown), (unknown), (unknown)	55
13	Exploring the Diabetic Gastroparesis Patient Experience: Patient Exit Interviews 2017 ·Advances in Therapy ·(unknown), David S. Reasner, Jennifer Hanlon, Sheri Fehnel	7
14	Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder 2015 ·Journal of Clinical Psychopharmacology ·Janet B. W. Williams, Kenneth A. Kobak, Earl L. Giller, David S. Reasner, (unknown), Michael J. Detke	5
15	Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder 2013 ·Psychiatry Research ·Seth C. Hopkins, David S. Reasner, Kenneth S. Koblan	11
16	Relationship Between Crevicular Aspartate Aminotransferase Levels and Periodontal Disease Progression 2001 ·Journal of Periodontology ·Richard J. Oringer, T. Howard Howell, Marc L. Nevins, David S. Reasner, G. H. G. Davis, (unknown), Joseph P. Fiorellini	32
17	The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients 1999 ·Journal of Allergy and Clinical Immunology ·Sandra M. Gawchik, (unknown), Michael Noonan, David S. Reasner, (unknown)	95
18	Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma☆☆☆★★★ 1998 ·Journal of Allergy and Clinical Immunology ·Harold S. Nelson, George Bensch, Warren Pleskow, Rachael L. DiSantostefano, (unknown), David S. Reasner, Thomas E. Rollins, Paul Rubin	153
19	Enantiospecific inhibition of ligature‐induced periodontitis in beagles with topical (S)‐ketoprofen 1997 ·Journal Of Clinical Periodontology ·David W. Paquette, Joseph P. Fiorellini, Gianluca Martuscelli, Richard J. Oringer, T. Howard Howell, John R. McCullough, David S. Reasner, Ray Williams	21
20	Alteration of the bed nucleus of the stria terminalis (BNST) in young female Djungarian hamsters (Phodopus campbelli) exposed to adult males 1993 ·Behavioral and Neural Biology ·David S. Reasner, Robert E. Johnston, Timothy J. DeVoogd	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact